Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-28

FDA Approved: SACUBITRIL AND VALSARTAN — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approves Alembic Pharmaceuticals Limited's original application for a generic fixed-dose combination of sacubitril and valsartan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sacubitril and valsartan (sacubitril/valsartan)

Snippet

ORIG AP for SACUBITRIL AND VALSARTAN (SACUBITRIL AND VALSARTAN)